TMPRSS2 and prostate carcinoma: In the present study, we used a three-marker fluorescence in situ hybridization (FISH) panel to detect TMPRSS2 and/or ERG rearrangements, AR gene amplification, and PTEN deletion in both primary and CRPC prostate cancer samples and compared the prevalence, concurrence, and interaction of these three markers.